Orthox

Private

AbingdonHealthcare & Life Scienceshttps://orthox.com/

Last Round

Series A

Feb 9, 2022

Total Funding Raised

$33.19M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Orthox is a medical technology company that develops tissue regenerative implants for cartilage and bone repair.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Advanced Materials, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

orthopedic implantsregenerative medicinecartilage repairmedical devicebiomaterialsbiodegradable implantsmeniscus repairtissue engineeringjoint repairfibroinscaffold technologysports medicinebiotechmedtechclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Orthox Comps

Public and private peers based on sector, stage, and business model.

Orthox comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Orthox Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Feb 9, 2022
Grant	Nov 1, 2019
Grant	Apr 1, 2017
Seed	Jun 30, 2015
Grant	Jul 11, 2014
Grant	Oct 29, 2013

View all Funding Rounds

Key People

Founding team and executive leadership

Nick Skaer

Founder and CEO

Founding Team

Orthox Investors

Notable investors and investment history

Orthox investors
Investor	Rounds
Perivoli Innovations	Series A
OTIF Ventures	Series A
Innovate UK	Grant
European Innovation Council Fund	Grant
Parkwalk Advisors	Seed, Series A
Additio Investment Group	Series A
Wellcome Trust	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 17, 2026
Monthly visitors increased 58% MoM, from 1.3K to 2K.

View all signals

Orthox Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Orthox Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Orthox's valuation, stock price, and market status.

Firmographic Details

HeadquartersAbingdon

Employee Range9

Year Founded2008

Last FundingFeb 9, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.